Items where authors include "Wilson, R.H."
Jump to: Article | Proceedings Paper
Number of items: 2.
Article
Woodcock, V.K., Clive, S., Wilson, R.H. et al. (11 more authors) (2018) A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424. British Journal of Cancer, 118 (6). pp. 770-776. ISSN 0007-0920
Proceedings Paper
Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.